Advertisement

Topics

Investors demand resignation of Mylan executives over pay packages

05:15 EDT 29 Jun 2017 | Pharmafile

As confidence in Mylan continues to fall and share prices plummet after last year’s EpiPen pricing scandal and subsequent PR faux pas, an investor group is calling for the resignation of the company’s Chairman and Director over its executive pay packages and price hiking practices.

read more

Original Article: Investors demand resignation of Mylan executives over pay packages

NEXT ARTICLE

More From BioPortfolio on "Investors demand resignation of Mylan executives over pay packages"

Advertisement
Quick Search
Advertisement
Advertisement